Global Human Cell Line Authentication Service Market Growth (Status and Outlook) 2025-2031

The global Human Cell Line Authentication Service market size is predicted to grow from US$ 381 million in 2025 to US$ 548 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Human cell line authentication service is a service that verifies and confirms the identity of cell lines through molecular biology technology. This service is mainly used to ensure that the cell lines used by researchers are consistent with their claimed identities, avoiding inaccurate or irreproducible experimental results caused by cell line contamination or misidentification.

United States market for Human Cell Line Authentication Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Human Cell Line Authentication Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Human Cell Line Authentication Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Human Cell Line Authentication Service players cover Eurofins, ATCC, Applied Biological Materials Inc. (abm), Johns Hopkins Medicine, Microsynth, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Human Cell Line Authentication Service Industry Forecast” looks at past sales and reviews total world Human Cell Line Authentication Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Cell Line Authentication Service sales for 2025 through 2031. With Human Cell Line Authentication Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Cell Line Authentication Service industry.

This Insight Report provides a comprehensive analysis of the global Human Cell Line Authentication Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Cell Line Authentication Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Cell Line Authentication Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Cell Line Authentication Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Cell Line Authentication Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Cell Line Authentication Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Short Tandem Repeat (STR) Profiling
Single Nucleotide Polymorphism (SNP) Genotyping
Others

Segmentation by Application:
Basic Research
Drug Development
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins
ATCC
Applied Biological Materials Inc. (abm)
Johns Hopkins Medicine
Microsynth
Generi Biotech
1st BASE
Labcorp
Multiplexion
LGC Standards

Please note: The report will take approximately 2 business days to prepare and deliver.